NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Revolution Medicines, Inc.
Stanford University
Revolution Medicines, Inc.
University Medical Center Goettingen
Hoffmann-La Roche
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Assistance Publique - Hôpitaux de Paris
Heidelberg University